Literature DB >> 30964163

The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines.

Y Zhang1, L-G Jia, P Wang, J Li, F Tian, Z-P Chu, S Kang.   

Abstract

OBJECTIVE: This study attempted to investigate the expression and significance of lncRNA HOST2 (human ovarian cancer-specific transcript 2) and microRNA let-7b in human papillomavirus (HPV)-positive cervical cancer (CC) tissues and cell lines. PATIENTS AND METHODS: The expression of levels of HOST2 and let-7b were detected by qRT-PCR in HPV-positive CC tissues and cell lines. The HPV-positive CaSki and HeLa cells were divided into the Blank, NC, pcDNA3.0-HOST2, siHOST2, let-7b mimic, and pcDNA3.0-HOST2+let-7b mimic groups. Dual-luciferase reporter gene assay was employed to verify the targeting relationship between HOST2 and let-7b, MTT and flow cytometry to determinate cell proliferation and apoptosis, and wound-healing and transwell assays to evaluate cell migration and invasion capabilities.
RESULTS: HOST2 was up-regulated but let-7b was down-regulated in HPV-positive CC tissues and cells. Dual-luciferase reporter gene assay confirmed the targeting relationship between HOST2 and let-7b. Over-expressed HOST2 reduced let-7b expression, promoted proliferation migration and invasion and inhibited the apoptosis of CaSki and HeLa cells; however, silencing HOST2 or overexpressing let-7b enhanced the expression of let-7b, inhibited proliferation migration and invasion, and promoted the apoptosis of CaSki and HeLa cells, and let-7b mimic could reverse the promoting effect of HOST2 on the growth of CC cells.
CONCLUSIONS: HOST2 was upregulated in HPV-positive CC tissues and cells, which could promote the proliferation, migration and invasion, but inhibit the apoptosis of HPV-positive CC cells via inhibition of let-7b.

Entities:  

Year:  2019        PMID: 30964163     DOI: 10.26355/eurrev_201903_17384

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  Beyond MicroRNAs: Emerging Role of Other Non-Coding RNAs in HPV-Driven Cancers.

Authors:  Mariateresa Casarotto; Giuseppe Fanetti; Roberto Guerrieri; Elisa Palazzari; Valentina Lupato; Agostino Steffan; Jerry Polesel; Paolo Boscolo-Rizzo; Elisabetta Fratta
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

2.  lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer.

Authors:  Linlin Song; Linlin Wang; Xiaoli Pan; Caihong Yang
Journal:  Braz J Med Biol Res       Date:  2020-01-13       Impact factor: 2.590

3.  Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.

Authors:  Aiping Dong; Bin Xu; Zhanzhao Wang; Xia Miao
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

4.  Silencing of let-7b-5p inhibits ovarian cancer cell proliferation and stemness characteristics by Asp-Glu-Ala-Asp-box helicase 19A.

Authors:  Xiujuan Huang; Hongxia Dong; Yang Liu; Fen Yu; Shunshi Yang; Zhen Chen; Jueying Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.

Authors:  Kaiyao Hua; Xiaochong Deng; Jiashu Hu; Changle Ji; Yunhe Yu; Jiayi Li; Xuehui Wang; Lin Fang
Journal:  J Exp Clin Cancer Res       Date:  2020-04-05

6.  Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.

Authors:  Xiaoqing Dou; Qun Zhou; Mingxiao Wen; Jiangyan Xu; Yingping Zhu; Shuzhen Zhang; Xianli Xu
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

7.  Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.

Authors:  Yan Kuang; Hong Xu; Fangfang Lu; Jiahua Meng; Yeye Yi; Huilan Yang; Hairui Hou; Hao Wei; Shanheng Su
Journal:  Cancer Sci       Date:  2020-11-21       Impact factor: 6.518

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.